Navigation Links
Better Risk Management Could Cut MRSA Infection Rates

The larger and busier an NHS hospital is, the higher the MRSA infection rate, research from// the Nottingham University Business School has revealed.

The impact of risk management standards on the frequency of MRSA infections in NHS hospitals study looked at how demanding risk management standards imposed by hospital insurers — and the premium discounts offered if these rigorous standards are met — could reduce MRSA infection rates.

Institutions with the highest number of 'bed days' for riskier treatments, particularly surgery and gynaecology, have an increased likelihood of infection. But financial incentives could play a role in controlling MRSA infection rates, potentially slashing the incidence of infection by between 11 and 20 per cent, the study shows.

MRSA infection costs the NHS £1bn a year in terms of prevention, compensation payments and additional treatment. Deaths involving MRSA rose from 51 in 1993 to 1,629 in 2005.

All NHS hospitals carry insurance to cover them against claims for illness and injuries caused by medical treatment. As with other insurance settings, the cover it provides reduces the need to try to minimise exposure to claims, because the insurer, not the hospital, will be paying the claim. In the NHS, the insurer, the NHS Litigation Authority (NHSLA), overcomes this problem by outlining strict risk management standards. The standards are increasingly demanding and — if they can demonstrate compliance with them — hospitals are granted increasing discounts on the premiums they pay the NHSLA for their cover. If the financial incentives implicit in these arrangements are effective, hospitals attaining higher risk management levels could face lower MRSA infection rates.

The study, led by Paul Fenn, Norwich Union Professor of Insurance Studies in the Nottingham University Business School, involved Professor Alastair Gray from the University of Oxford and Professor Neil Rickman fr om the University of Surrey. The team looked at data from all NHS hospitals in the UK between 2001 and 2005, including MRSA infection rates, hospital size and mix of cases, bed utilisation rates and risk management levels. They found that the introduction of higher risk management standards, including hand hygiene and infection control measures, reduced the incidence of infection in hospitals by between 11 and 20 per cent after allowing for all other variations in infection rates.

Larger hospitals were found to have higher infection rates, particularly those with higher proportions of patients undergoing surgical or gynecological treatment. And the “busier” the hospital — the closer it is to full capacity — the higher the incidence of MRSA infection.

Professor Fenn said: “Our research has demonstrated that hospital management has responded to financial incentives by adopting higher risk management standards, and where this happens, patient safety tends to improve.”

Source-Eurekaler
SRM/V
'"/>




Related medicine news :

1. Better prostate cancer detection
2. Better Treatment for obesity
3. For a Better Memory
4. Baby Talk Better Than Adult Speech
5. Drug Combo Works Better for children with ADHD, Tics
6. Better skin with lasers
7. Better diabetes treatment promises Vanadium
8. Better Prostate Cancer Test
9. Better Drug for Heart Transplant
10. Better Diet Even Late in Life May Prolong It
11. Better Care Required for Breast Cancer Survivors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is ... the treatment of acute or chronic problems, I focus on preventative care with all my ... If you have any questions, always feel free to contact my office and my trained ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement ... quarterback position. The former overall number one pick in the 2001 NFL Draft, to ... holds the record for the most career rushing yards by a quarterback (6,109) and ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/18/2017)... -- Cardinal Health (NYSE: CAH ) today is ... share (EPS) guidance and providing a preliminary view on ... this morning,s announcement of the planned acquisition of Medtronic,s ... Cardinal Health now believes that fiscal 2017 ... bottom of its previous guidance range of $5.35 to ...
(Date:4/18/2017)... SAN DIEGO , April 18, 2017  Astute ... previewed a case series to be presented at the ... , which begins today and continues through April 22. ... and IGFBP-7 , used to assess risk for acute ... acute decompensated heart failure (ADHF). Elevated ...
Breaking Medicine Technology: